CAGRILINTIDE - 10mg
£54.99Price
Cagrilintide – Long-Acting Amylin Analog Peptide Therapeutic
Technical & chemical profile
Name: Cagrilintide (development code NNC0174-0833)
Class: Long-acting amylin analogue / dual amylin and calcitonin receptor agonist (DACRA)
Mechanism: Mimics amylin function and engages amylin and calcitonin receptors, promoting satiety and delayed gastric emptying.
Administration: Once-weekly subcutaneous injection (research/clinical)
Pharmacokinetics: Extended duration of action through peptide lipidation and albumin binding modifications.
Important Notice:
This product is intended for research and investigational use only. Not approved for human or veterinary consumption. All information provided is for educational and research purposes.